MU

Mark Uden

GL Glaxo Group Limited: 4 patents #243 of 1,368Top 20%
OL Oxford Biomedica (Uk) Limited: 2 patents #17 of 56Top 35%
FL F-Star Therapeutics Limited: 1 patents #20 of 33Top 65%
Overall (All Time): #397,354 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
12312408 Multispecific anti-TCR delta variable 1 antibodies Mihriban Tuna, Joshua Freedman, Natalie Mount 2025-05-27
11667887 Method of producing a recombinant protein Gary Brian Finka, Michael HOARE, Ioannis Voulgaris 2023-06-06
11566347 Antibody variants Valeriu Damian, Austin Keith Doyle, Laura Maria Halo, Emma R. Harding, Xuan Hong +1 more 2023-01-31
11254753 Antibodies with reduced binding to process impurities Hella Bosteels, Shugui Chen, Kayeleigh Farrow, Richard KUCIA-TRAN, William J. Lewis +1 more 2022-02-22
11203632 Antibody variants Valeriu Damian, Austin Keith Doyle, Laura Maria Halo, Emma R. Harding, Xuan Hong +1 more 2021-12-21
11098312 Method of producing a recombinant protein Robyn Alexandra Emmins, Gary Brian Finka, Michael HOARE, Alan Peter Lewis, William J. Lewis +2 more 2021-08-24
10633673 Production methods Ekaterini Kotsopoulou 2020-04-28
9534246 Method for selecting high producing cell lines Ekaterini Kotsopoulou, Richard Priest 2017-01-03
9163249 Production methods Ekaterini Kotsopoulou 2015-10-20
7303910 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site Christopher R. Bebbington, Susan Kingsman, Alan Kingsman, Kyriacos Mitrophanos 2007-12-04
6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site Christopher R. Bebbington, Susan Kingsman, Alan Kingsman, Kyriacos Mitrophanos 2004-10-26
6783981 Anti-viral vectors Kyriacos Mitrophanous 2004-08-31